Slideset
View More
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
In this slideset from Clinical Care Options (CCO), experts provide insights on HER2 testing and resulting implications for treatment in breast cancer
Mark D. Pegram, MD
Michael F. Press, MD, PhD
Released: July 30, 2020
From Clinical Care Options (CCO), download this PDF summarizing HER2, HER3, and TROP2 testing and targeted therapeutics
Mark D. Pegram, MD
Michael F. Press, MD, PhD
Released: July 30, 2020
A living slideset on optimal management of breast cancer during the COVID-19 pandemic that will be updated as the situation evolves and new data emerge
Harold J. Burstein, MD, PhD
Hope S. Rugo, MD
Released: July 28, 2020
From Clinical Care Options (CCO), review advances in testing for and targeting HER2, HER3, and TROP2 with this commentary by Mark D. Pegram, MD
Mark D. Pegram, MD
Released: July 23, 2020
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.